“Skin Clearance and Itch Relief in Black or African American Patients With Moderate-to-Severe Atopic Dermatitis Treated With Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s615. Accessed April 20, 2026. https://skin.dermsquared.com/skin/article/view/3873.